Looks like MM is not done with #BIO yet 👀
Feels like the market maker in #BioProtocol is pushing

BIOUSDT toward the $0.11–0.13 liquidity zone.
If that assumption is correct — there may still be a chance to catch part of a +200–250% move in the coming days.
For context:
the first impulse from the bottom already delivered +170%+.
So the story might not be over yet.
But the key question remains:
is there real fundamental backing —
or just a liquidity-driven pump?
What do you think — continuation or time to take profits?
______________
◆ Follow us ❤️ for daily crypto insights & updates!
🚀 Don’t miss out on important market moves
🧠 DYOR | This is not financial advice, just thinking out loud
Feels like the market maker in #BioProtocol is pushing
If that assumption is correct — there may still be a chance to catch part of a +200–250% move in the coming days.
For context:
the first impulse from the bottom already delivered +170%+.
So the story might not be over yet.
But the key question remains:
is there real fundamental backing —
or just a liquidity-driven pump?
What do you think — continuation or time to take profits?
______________
◆ Follow us ❤️ for daily crypto insights & updates!
🚀 Don’t miss out on important market moves
🧠 DYOR | This is not financial advice, just thinking out loud
🎁 -20% for ALL trading fees at #OKX 👇
okx.com/join/20PSTRADE
🔥 V-I-P 👉 pstrade.top/en/
🔵 Telegram 👉 t.me/pstrade_eng
🤖 Trading Bots 👉 copytrading.space/en/
📞 t.me/P_S_trades 📝
okx.com/join/20PSTRADE
🔥 V-I-P 👉 pstrade.top/en/
🔵 Telegram 👉 t.me/pstrade_eng
🤖 Trading Bots 👉 copytrading.space/en/
📞 t.me/P_S_trades 📝
相关出版物
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
🎁 -20% for ALL trading fees at #OKX 👇
okx.com/join/20PSTRADE
🔥 V-I-P 👉 pstrade.top/en/
🔵 Telegram 👉 t.me/pstrade_eng
🤖 Trading Bots 👉 copytrading.space/en/
📞 t.me/P_S_trades 📝
okx.com/join/20PSTRADE
🔥 V-I-P 👉 pstrade.top/en/
🔵 Telegram 👉 t.me/pstrade_eng
🤖 Trading Bots 👉 copytrading.space/en/
📞 t.me/P_S_trades 📝
相关出版物
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
